BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 520669)

  • 1. Benefits and risks of attenuated polio vaccine strains in a community immunized with inactivated polio vaccine.
    Rossier E; Phipps PH; Pépin O
    Dev Biol Stand; 1979; 43():179-85. PubMed ID: 520669
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunization against poliomyelitis: risk/benefit/cost in a changing context.
    Salk J
    Dev Biol Stand; 1979; 43():151-7. PubMed ID: 230106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Findings on the success of vaccination and revaccination with live and inactivated vaccines against poliomyelitis].
    Dostal V; Haenzel I; Sturm W
    Schweiz Med Wochenschr; 1969 Sep; 99(37):1322-4. PubMed ID: 4309326
    [No Abstract]   [Full Text] [Related]  

  • 4. Poliomyelitis vaccines in Belgium: 20 years of experience.
    Andre FE
    Dev Biol Stand; 1979; 43():187-93. PubMed ID: 230109
    [No Abstract]   [Full Text] [Related]  

  • 5. [Poliomyelitis vaccination in Denmark].
    Petersen I
    Ugeskr Laeger; 1985 Jan; 147(4):265-9. PubMed ID: 3976028
    [No Abstract]   [Full Text] [Related]  

  • 6. [Worldwide eradication of poliomyelitis].
    Rasch G; Schreier E; Kiehl W; Kurth R
    Wien Klin Wochenschr; 2001 Oct; 113(20-21):839-45. PubMed ID: 11732120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Problems of prevention and control of poliomyelitis in Poland].
    Mazurowska-Magdzik W; Bucholc B; Janaszek-Seydlitz W; Szkoda T; Magdzik W
    Przegl Epidemiol; 2010; 64(3):341-7. PubMed ID: 20976944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vaccination against poliomyelitis. Formation of immunity evaluated according to the results of serological surveys].
    Zabicka J
    Przegl Epidemiol; 1981; 35(3):385-9. PubMed ID: 6276928
    [No Abstract]   [Full Text] [Related]  

  • 9. [Will Salk's polio vaccination be used again?].
    Stickl H
    Fortschr Med; 1978 Apr; 96(13):688-94. PubMed ID: 631710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Polio disposed of, starting in and thanks to the Netherlands?].
    Kapsenberg JG
    Ned Tijdschr Geneeskd; 1983 Jul; 127(29):1303-5. PubMed ID: 6888596
    [No Abstract]   [Full Text] [Related]  

  • 11. Polio eradication in India: how far are we from reaching the goal?
    Banerjee K; Sahu S; Bandyopadhyay S
    Indian J Pediatr; 2001 Mar; 68 Suppl 1():S6-14. PubMed ID: 11411387
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibody to poliovirus in older children and young adults in Israel and the use of poliovaccines for the immunization of the seronegatives.
    Goldblum N; Kra-Oz Z; Swartz T
    Dev Biol Stand; 1979; 43():173-7. PubMed ID: 230108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [End phase challenges of poliomyelitis eradication programme realization].
    Jarzabek Z
    Przegl Epidemiol; 2005; 59(1):59-68. PubMed ID: 16013411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk management in a polio-free world.
    Bruce Aylward R; Sutter RW; Cochi SL; Thompson KM; Jafari H; Heymann D
    Risk Anal; 2006 Dec; 26(6):1441-8. PubMed ID: 17184391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Polio vaccination 1955-1967 and future polio vaccinations].
    von Magnus H
    Ugeskr Laeger; 1967 Dec; 129(52):1759-62. PubMed ID: 5587496
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunization and decrease in mortality of acute poliomyelitis].
    Laflor Carot V; Bernalte Benazet A; Carpio JM; Cornejo JA
    Rev Enferm; 1984 Jun; 7(70):22-30. PubMed ID: 6566431
    [No Abstract]   [Full Text] [Related]  

  • 17. Benefits and risks of killed polio vaccine. Experiences in Finland.
    Penttinen K
    Dev Biol Stand; 1979; 43():159-63. PubMed ID: 230107
    [No Abstract]   [Full Text] [Related]  

  • 18. Poliomyelitis vaccination benefits--versus risk.
    Assaad F
    Dev Biol Stand; 1979; 43():141-50. PubMed ID: 520666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Criteria for control of infectious diseases with poliomyelitis as an example.
    Evans AS
    Prog Med Virol; 1984; 29():141-65. PubMed ID: 6322231
    [No Abstract]   [Full Text] [Related]  

  • 20. Shedding of virulent poliovirus revertants during immunization with oral poliovirus vaccine after prior immunization with inactivated polio vaccine.
    Abraham R; Minor P; Dunn G; Modlin JF; Ogra PL
    J Infect Dis; 1993 Nov; 168(5):1105-9. PubMed ID: 8228342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.